Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Pharma Marketing KPIs Shaping the Future of Engagement
Pharma marketing KPIs should measure outcomes like doctor engagement, prescription uptake, and patient adherence to deliver growth and boardroom credibility.
|
Patient Engagement vs Activation: A 10‑Step Playbook for Indian Pharma
Pharma companies in India are under pressure to go beyond brand promotion and focus on real patient outcomes. Engagement programs, apps, awareness campaigns, and helplines are everywhere. But the…
|
How to Audit Your Pharma Marketing Tech Stack in 7 Days
If you want to audit your pharma marketing tech stack and get real answers, not a 3-month consulting project that ends in a PowerPoint, you can do it in a week. The key is focus. You’re not…
|
Building MarTech for Pharma That Works for India
MarTech for pharma in India is not just a cut-and-paste job from what works in the US or Europe. Our regulatory frameworks are different. Our healthcare ecosystem is different. Our geography,…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
